483
Laboratorios Haymann S.A.FDA 483 - Laboratorios Haymann S.A. - May 16, 2011
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Laboratorios Haymann S.A. in Montevideo, Uruguay, a manufacturer of drug products and active pharmaceutical ingredients, revealed two significant observations. The firm failed to follow written procedures for equipment cleaning, as evidenced by observed residue on equipment marked as clean. Additionally, multiple batches of Active Pharmaceutical Ingredient (API) were not included in the stability monitoring program.
Open in Dashboard
ID · c281d2a4-e4b1-4c7e-8417-6d0534b1a67b